Navigation Links
Report reveals why personalizing support for women with breast cancer could save lives
Date:11/22/2013

SUMMIT, N.J., Nov. 22, 2013 /PRNewswire/ -- Personalizing support for women living with breast cancer could help them achieve better health outcomes through improved adherence, according to a new White Paper published by Atlantis Healthcare.    

(Logo: http://photos.prnewswire.com/prnh/20130627/MM38791)

This latest report from the Adherence Research Summarized™ series has been published to help healthcare providers, organized customers and pharma work with patients to overcome the challenges they face while taking preventative breast cancer therapies.

The issue of non-adherence in breast cancer was recently highlighted by a study from the University of Glasgow showing that improved adherence to Tamoxifen, a breast cancer hormone therapy, could prevent 434 deaths each year among women with breast cancer, and save up to £30 million (equivalent of nearly $50 million) in healthcare costs.[1]

"Research indicates as many as 41% of women choose to discontinue their breast cancer treatment," confirms John Weinman, Professor of Psychology as applied to Medicine at King's College London, who reviewed this new report. "While this may seem surprising, it's important to consider why they make this decision."

"Research shows there are certain factors that contribute to non-adherence in breast cancer, including treatment side effects, an individual's personal beliefs about their treatment and condition, and the quality of their healthcare consultations."

Professor Weinman explains that there are ways to help women overcome these challenges.

"The evidence clearly shows that for a support intervention to improve adherence, it must be personalized. As reasons for non-adherence differ between individuals, interventions should be tailored according to a person's unique needs and preferences."

As described in the report, this approach is currently being investigated by other scientists in breast cancer. In a major project funded by the Breast Cancer Research Foundation, Professor Annette Stanton from the University of California and her colleagues Professor Keith Petrie (University of Auckland) and Dr. Ann Partridge (Harvard Medical School) recruited over 1,000 women who had taken hormone therapy for breast cancer within the previous twelve months.  Their study concluded that different women have different support needs, and these must be addressed to have a significant impact on adherence rates. "Some women may truly benefit from information and education about the importance of medication in terms of survival benefit. Some women may need information on how to deal with the side effects," says Professor Stanton.

Professor Weinman concludes, "Just as treatments for breast cancer are becoming increasingly personalized, so too should interventions designed to support patients taking them."

To download the breast cancer Adherence Research Summarized™ report, click here.

About Atlantis Healthcare
Established in 1993, Atlantis Healthcare creates and executes tailored patient support programs and personalized interventions to address treatment adherence across a wide range of chronic and acute diseases, worldwide.  Led by one of the world's largest health psychology teams, our patient-centric approach is designed to improve health outcomes and deliver optimal value for all healthcare stakeholders. 

Atlantishealthcare.com/US

[1] McCowan C, Wang S, Thompson AM, et al, The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study, Br J Cancer. 2013 Sep 3;109(5):1172-80. doi: 10.1038/bjc.2013.464. Epub 2013 Aug 15.


'/>"/>
SOURCE Atlantis Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
5. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
6. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
7. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
8. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
9. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
10. Chindex International, Inc. to Report First Quarter 2012 Financial Results
11. Pharma IQs Solubility Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... Inc. (Nasdaq: HOLX ) announced today ... quarter ended March 26, 2016.  GAAP diluted earnings ... non-GAAP diluted EPS of $0.47 increased 14.6%.  Revenue ... basis, and 6.3% on a constant currency basis.  ... highlighted by 14.6% growth in non-GAAP EPS," said ...
Breaking Medicine Technology:
(Date:4/29/2016)... Fl (PRWEB) , ... April 29, 2016 , ... ... recently notified by the Accreditation Council for Graduate Medical Education (ACGME) that it ... , This is the first accreditation of three residency programs that Memorial is ...
(Date:4/29/2016)... ... April 29, 2016 , ... The American ... productivity, stability, even security. Most importantly, employees are the single most important asset ... American workers so unhappy? , Just under half of American workers are emotionally ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart is celebrating ... new location in the Exchange Furniture Mall at 112 Vilseck Road in Fort Stewart. ... Smart TV. Plus attendees will have the opportunity to meet general dentists Thomas Richards, ...
(Date:4/29/2016)... City, Missouri (PRWEB) , ... April 29, 2016 , ... ... traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes body ... strain on their wrists and hands when using the crutches than with other crutches. ...
(Date:4/29/2016)... ... 29, 2016 , ... Dr. Robert Mondavi, one of the dentists in ... is a fast-growing field as more patients are discovering the many different ways they ... the options currently available to them and which ones might work for their smiles. ...
Breaking Medicine News(10 mins):